These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2441447)

  • 1. The place of pharmacologic treatment in benign prostatic hyperplasia.
    Caine M
    Semin Urol; 1985 Nov; 3(4):311-6. PubMed ID: 2441447
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2000; (2):3-5. PubMed ID: 11186726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenoxybenzamine in prostatic pathology. 300 cases (author's transl)].
    Lardennois B; El Khansa A; Amory JP; Coulon JM; Lemaire P
    J Urol (Paris); 1981; 87(4):243-8. PubMed ID: 6167646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.
    Crawford ED
    BJU Int; 2005 Jun; 95 Suppl 4():1-5. PubMed ID: 15871729
    [No Abstract]   [Full Text] [Related]  

  • 5. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach].
    Jolliet P; Bourin M
    Therapie; 1998; 53(1):61-6. PubMed ID: 9773101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 7. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 8. [The objective of medical treatment: relieve the symptoms or stop the course?].
    Desgrandchamps F
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():14-6. PubMed ID: 16649585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience in the use of doxazosin in patients with benign hyperplasia of the prostate].
    Lopatkin NA; Loran OB; Pushkar' DIu; Perepanova TS; Tevlin KP
    Urol Nefrol (Mosk); 1998; (3):3-5. PubMed ID: 9644978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function.
    Kaplan SA
    Urology; 2004 Mar; 63(3):428-34. PubMed ID: 15028431
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamic variables: novel and perhaps better predictors of progression in benign prostatic hyperplasia.
    Armitage JN; Emberton M
    BJU Int; 2006 Mar; 97(3):439-41. PubMed ID: 16469003
    [No Abstract]   [Full Text] [Related]  

  • 12. BPH alpha blocker therapy.
    Vela-Navarrete R
    J Urol (Paris); 1995; 101(1):26-8. PubMed ID: 7545722
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
    Caine M
    Urol Clin North Am; 1990 Aug; 17(3):641-9. PubMed ID: 1695784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of alpha1-adrenoceptors on prostate cancer growth.
    Stamatiou K; Skolarikos A; Sofras F
    Urology; 2008 Apr; 71(4):756-7. PubMed ID: 18291511
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia].
    Sugino Y; Fukuzawa S; Takeuchi H; Taki Y; Hashimura T; Soeda T; Araki I
    Hinyokika Kiyo; 2003 Aug; 49(8):445-9. PubMed ID: 14518379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment to short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gravas S
    Int J Urol; 2010 Oct; 17(10):875. PubMed ID: 20887633
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications.
    Fine SR; Ginsberg P
    J Am Osteopath Assoc; 2008 Jul; 108(7):333-7. PubMed ID: 18648026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough treatment for prostate enlargement.
    Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of alpha 1-blockade in benign prostatic hyperplasia.
    Brawer MK
    J Clin Pharmacol; 1993 Sep; 33(9):891-5. PubMed ID: 7693769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.